首页/数据集/Table S8 from Clinical Importance of the lncRNA NEAT1 in Cancer Patients Treated with Immune Checkpoint Inhibitors

Table S8 from Clinical Importance of the lncRNA NEAT1 in Cancer Patients Treated with Immune Checkpoint Inhibitors

Figshare2023-06-13 更新2026-04-28 收录

肿瘤免疫治疗生物标志物

巨噬细胞基因表达分析

数据链接：

https://figshare.com/articles/dataset/Table_S8_from_Clinical_Importance_of_the_lncRNA_i_NEAT1_i_in_Cancer_Patients_Treated_with_Immune_Checkpoint_Inhibitors/23507174 数据链接链接失效反馈

官方服务：

资源简介：

Genes enriched in NEAT1-high macrophages

应用场景：

创建时间：

2023-06-13

肿瘤免疫治疗生物标志物

口咽微生物组

Lung cancer is a leading cause of cancer mortality, with NSCLC comprising the majority of cases. Despite the advent of immune checkpoint inhibitors(ICIs), a significant number of patients fail to achi

DataCite Commons2025-06-01 更新30

Additional file 2 of HNRNPC, a predictor of prognosis and immunotherapy response based on bioinformatics analysis, is related to proliferation and invasion of NSCLC cells

肺癌基因研究

肿瘤免疫治疗生物标志物

Additional file 2. The profile of the analyzed 994 NSCLC samples and their information.

Figshare2024-03-04 更新20

Table_1_TNF-Alpha Pathway Alternation Predicts Survival of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.pdf

肿瘤免疫治疗生物标志物

非小细胞肺癌精准治疗

Translational research on immune checkpoint inhibitors (ICIs) has been underway. However, in the unselected population, only a few patients benefit from ICIs. Therefore, screening predictive markers o

NIAID Data Ecosystem10

PD-L1 expression as predictor of immunotherapy eligibility in penile squamous cell carcinoma patients.xlsx

肿瘤免疫治疗生物标志物

泌尿生殖肿瘤临床病理

PD-L1 is a tumor marker that co-stimulates the receptor PD-1 to suppress T-cell-mediated antitumor immunity. Seventy-six biopsy sample were taken from patients diagnosed with penile squamous cell carc

NIAID Data Ecosystem20

Table_1_De Novo Mutation in Non-Tyrosine Kinase Domain of ROS1 as a Potential Predictor of Immune Checkpoint Inhibitors in Melanoma.xlsx

肿瘤免疫治疗生物标志物

黑色素瘤基因组学

PurposeDespite the success of targeted therapy in c-ros oncogene 1 (ROS1)-rearranged cancers, especially non-small cell lung cancer (NSCLC), the clinical significance of ROS1 de novo mutation has not

NIAID Data Ecosystem10

Table S8 from Clinical Importance of the lncRNA NEAT1 in Cancer Patients Treated with Immune Checkpoint Inhibitors

资源简介：

相关数据集